ILLUMINA, INC. (ILMN)

NASDAQ · Instruments & Medical Devices · Laboratory Analytical Instruments

Price

$255.38

Day

+3.20%

Market cap

$38.56B

P/E

46.7

Close 2026-09-23.

The company

Services We offer support services to customers who have purchased our products. In addition, we provide whole-genome sequencing, genotyping, NIPT, and product support services. Human whole-genome sequencing services are provided through our CLIA-certified, CAP-accredited laboratory. Using our services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies).

From Item 1: Services.

By product & service

• Consumables — 74%
• Service — 15%
• Instruments — 11%

Institutional holders

Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.

• Capital World Investors — $2.71B
• BlackRock, Inc. — $1.63B
• VANGUARD PORTFOLIO MANAGEMENT LLC — $1.17B
• VANGUARD CAPITAL MANAGEMENT LLC — $1.16B
• STATE STREET CORP — $1.14B
• WCM INVESTMENT MANAGEMENT, LLC — $1.12B
• BlackRock, Inc. — $760.78M
• PRIMECAP MANAGEMENT CO/CA/ — $617.98M

Insider trades

Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.

• Meister Keith A. (Director) sold 7,500 shares at $217.28 on 2026-09-04
• Meister Keith A. (Director) sold 100,650 shares at $218.39 on 2026-09-04
• Meister Keith A. (Director) sold 11,351 shares at $219.18 on 2026-09-04
• Meister Keith A. (Director) sold 8,439 shares at $215.20 on 2026-09-03
• Meister Keith A. (Director) sold 13,261 shares at $216.38 on 2026-09-03
• Meister Keith A. (Director) sold 14,196 shares at $217.29 on 2026-09-03

Recent filings

• 4 — 2026-09-10
• 4 — 2026-09-09
• 144 — 2026-09-04
• 4 — 2026-09-04
• 144 — 2026-08-27
• 4 — 2026-08-27
• 144 — 2026-08-25
• 144 — 2026-08-21
• 4 — 2026-08-21
• 144 — 2026-08-20